LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant
This grant, the largest it has received from the Resource Center, will allow the company to conduct a pivotal animal study and generate all the other required data to file an Investigational Device Exemption (IDE) application with the FDA to start a clinical trial.
The clinical use of this product is expected to enhance bone healing, reduce infection rates, and improve the cosmetic outcome of these procedures for patients while eliminating the need for metal fixation hardware.
his study constitutes the first clinical use of Tetranite®, a bone adhesive biomaterial. The purpose of the study is to show the safety and efficacy of Tetranite in immediately stabilizing dental implants following tooth extractions and its ability to obviate a costly, complex, and lengthy bone grafting procedure to accelerate the overall treatment timeframe for the many patients who suffer tooth loss.